Page last updated: 2024-10-26

dipyridamole and Anorexia Nervosa

dipyridamole has been researched along with Anorexia Nervosa in 1 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Anorexia Nervosa: An eating disorder that is characterized by the lack or loss of APPETITE, known as ANOREXIA. Other features include excess fear of becoming OVERWEIGHT; BODY IMAGE disturbance; significant WEIGHT LOSS; refusal to maintain minimal normal weight; and AMENORRHEA. This disorder occurs most frequently in adolescent females. (APA, Thesaurus of Psychological Index Terms, 1994)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sixma, JJ1
Trieschnigg, AM1
de Graaf, S1
Bouma, BN1

Trials

1 trial available for dipyridamole and Anorexia Nervosa

ArticleYear
In vivo inhibition of human platelet function by VK 744.
    Scandinavian journal of haematology, 1972, Volume: 9, Issue:3

    Topics: Adult; Anorexia Nervosa; Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Clot Retractio

1972